Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 16th October 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dopharma to acquire Boehringer Ingelheim production site
The move follows the presentation of Boehringer’s animal health strategic orientations.

Sale of Saint-Herblon site expected to complete in early 2019

Boehringer Ingelheim has announced the sale of its production site in Saint-Herblon, France, to Dutch company Dopharma.

First announced in October last year, the move follows the presentation of Boehringer’s animal health strategic orientations.

The group confirmed its strategy to focus on advanced and preventative healthcare; Saint-Herblon mainly produces generics and antibiotics for livestock.

Dopharma is an independent, family-owned company that develops, produces and distributes veterinary products for livestock.

Erick Lelouche, president of Boehringer Ingelheim Animal Health in France, said: “I am convinced that this project will offer a solid foundation for the future to the site and its employees. Indeed, we will collaborate with Dopharma Saint-Herblon that will produce some of our specialized products during the coming years.”

The sale is expected to complete by the end of the first quarter of 2019, after the legal and consultation process is finalised.

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.